Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/28/2012US8252839 Compounds and methods for delivery of prostacyclin analogs
08/28/2012US8252838 Diclofenac topical formulation
08/28/2012US8252837 Tamibarotene capsule preparation
08/28/2012US8252836 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease
08/28/2012US8252835 Compounds and methods for treating estrogen receptor-related diseases
08/28/2012US8252834 Dendrimer conjugates
08/28/2012US8252833 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists
08/28/2012US8252832 Kinesin inhibitors as cancer therapeutics
08/28/2012US8252831 Imidazole-2-benzamide compounds useful for the treatment of osteoarthritis
08/28/2012US8252830 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors
08/28/2012US8252829 Aminopyrrolidinone derivatives and uses thereof
08/28/2012US8252828 S-triazolyl α-mercapto acetanilides as inhibitors of HIV reverse transcriptase
08/28/2012US8252826 Cyclopentyl- and cycloheptylpyrazoles
08/28/2012US8252825 Angiotensin II receptor antagonists
08/28/2012US8252824 Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
08/28/2012US8252823 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof
08/28/2012US8252822 Heterocyclic compounds and uses as anticancer agents
08/28/2012US8252821 Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound
08/28/2012US8252820 1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as PTP-as inhibitors
08/28/2012US8252819 Low-melting biocidal formulation
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252817 Dipyridyl-dihydropyrazolones and their use
08/28/2012US8252816 [1] N-(2-fluoro-4-(1-oxo-1-((2-(4-(N-phenylpropionamido)piperidin-1-yl)-6-(trifluoro-methyl)pyridin-3-yl)methylamino)propan-2-yl)phenyl)-N-(methylsulfonyl)propionamide; for treating acute pain, chronic pain, neuropathic pain and visceral pain; neurodegenerative disease, airway diseases
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252814 Agents and crystals for improving excretory potency of urinary bladder
08/28/2012US8252813 Salt and crystalline forms thereof of a drug
08/28/2012US8252812 Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof
08/28/2012US8252811 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
08/28/2012US8252810 Bicycloamine derivatives
08/28/2012US8252809 Compositions for treating insomnia
08/28/2012US8252808 Process and compounds for the production of (+)opiates
08/28/2012US8252807 Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products
08/28/2012US8252806 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine; 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-(4-morpholin-4-yl-phenyl)-amine; respiratory diseases, epilepsy, convulsions, seizures, gastrointestinal dysfunction, ischaemia, psychosis, schizophrenia, anxiety, depression, Alzheimer's disease
08/28/2012US8252805 Forms of lapatinib ditosylate and processes for preparation thereof
08/28/2012US8252804 Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same
08/28/2012US8252803 Piperidine derivatives
08/28/2012US8252802 Chemical compounds
08/28/2012US8252801 Treatment of schizophrenia and related disorders
08/28/2012US8252800 Protein tyrosine kinase inhibitors
08/28/2012US8252799 Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds
08/28/2012US8252798 Purine compounds
08/28/2012US8252797 Heterocyclic compounds as adenosine receptor antagonist
08/28/2012US8252796 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof
08/28/2012US8252795 Imidazopyridazinecarbonitriles useful as kinase inhibitors
08/28/2012US8252794 Composition for regenerative treatment of cartilage disease
08/28/2012US8252793 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
08/28/2012US8252792 Pyrimidine derivatives as PI3K inhibitors
08/28/2012US8252791 Purine compounds as cannabinoid receptor blockers
08/28/2012US8252790 Pyrazole-3-carboxamide derivative having 5-HT2B receptor antagonist activity
08/28/2012US8252789 Compositions and methods for treating lysosomal disorders
08/28/2012US8252788 Therapeutic compounds
08/28/2012US8252787 Protein kinase inhibitors
08/28/2012US8252786 Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses
08/28/2012US8252785 Aryl sulfonamides as bradykinin-B1-receptor antagonists
08/28/2012US8252783 Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
08/28/2012US8252782 Monocarbams
08/28/2012US8252781 1,2-diazetidin-3-one derivatives and drugs containing same
08/28/2012US8252780 Organometallic complexes as therapeutic agents
08/28/2012US8252779 Analogs of benzoquinone-containing ansamycins and methods of use thereof
08/28/2012US8252778 Highly fluorinated oils and surfactants and methods of making and using same
08/28/2012US8252777 7, 8 and 9-substituted tetracycline compounds
08/28/2012US8252776 Minocycline oral dosage forms for the treatment of acne
08/28/2012US8252775 Method of treating multiple sclerosis with phosphocholine containing lipids
08/28/2012US8252774 5-azaindole bisphosphonates
08/28/2012US8252773 Combination therapy with organic arsenicals
08/28/2012US8252772 Hyperthermic technologies and therapeutic uses thereof
08/28/2012US8252771 A modified chitosan and a prostaglandin, prostamide, non-steroidal anti-inflammatory drug, or a corticosteroid; opthalmic drug delivery solution; improved bioavailability
08/28/2012US8252770 Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis
08/28/2012US8252769 Eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (ARA) and two indigestible oligosaccharides synergistically reduce reduce intestinal permeability by simultaneous reduction of tight junction permeability and stimulation of mucus production
08/28/2012US8252768 Designer therapy of pancreatic tumors
08/28/2012US8252767 Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
08/28/2012US8252766 Use of spongosine for the treatment of pain
08/28/2012US8252765 Treatment of cancer by inhibition of IGFBPs and clusterin
08/28/2012US8252762 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
08/28/2012US8252760 Compositions and methods for diagnosing and treating melanoma
08/28/2012US8252753 Oligonucleotide and the use thereof for modulating an isoform C beta-1 protein-kinase in the form of a skin depigmentation agent
08/28/2012US8252752 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use
08/28/2012US8252751 Organic compounds
08/28/2012US8252750 Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale
08/28/2012US8252742 Methods for enhancing the quality of life of a senior animal
08/28/2012US8252596 Methods and materials for treating conditions associated with metabolic disorders
08/28/2012US8252547 In vitro control of protein synthesis in mammalian cells by IP3 receptor-binding protein
08/28/2012US8252524 Method of screening pharmaceutical compositions that promote nuclear transfer of Cdc42 protein
08/28/2012US8252520 Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases
08/28/2012US8252336 Escitalopram and solid pharmaceutical composition comprising the same
08/28/2012US8252335 Finely powdered sucrose and a polylactic acid absorbing agent; the powder forms a cake when applied to a wound and subject to wound secretions; self-sterilizing; different viscosities to suit all kinds of wound; not painful to apply; does not disrupt the architecture of the healing wounds
08/28/2012US8252333 Biodegradable, non-toxic biological adhesive for use in abdominal surgery
08/28/2012US8252332 Gastric retained gabapentin dosage form
08/28/2012US8252327 Oral controlled release dosage form
08/28/2012US8252325 Liposome-encapsulated glutathione for oral administration
08/28/2012US8252322 Delivery system with increased bioavailability
08/28/2012US8252320 Transdermal delivery system for sufentanil
08/28/2012US8252319 patches has pressure-sensitive adhesive matrix containing a polyisobutylene, free of permeation enhancer, for drug deliverying sufentanil through the skin to provide an analgesic effect, pain management; sustained release, side effect reduction
08/28/2012US8252312 Oral solid composition comprising a lipid absorption inhibitor
08/28/2012US8252309 Dietary supplement energy-providing to skeletal muscles
08/28/2012US8252308 Feminine anti-itch gel
08/28/2012US8252307 Method for treating and/or preventing retinal diseases with sustained release corticosteroids
08/28/2012US8252306 Process for preparing a semi-solid delivery vehicle comprising granisetron
08/28/2012US8252305 Methods of treating emesis utilizing semi-solid delivery pharmaceutical compositions comprising granisetron
08/28/2012US8252304 Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron
1 ... 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 ... 7860